Home/Vincerx Pharma/John H. Lee, M.D., Ph.D.
JH

John H. Lee, M.D., Ph.D.

Former Chief Medical Officer

Vincerx Pharma

Therapeutic Areas

Vincerx Pharma Pipeline

DrugIndicationPhase
VIP236Metastatic Solid TumorsPhase 1
VIP943Relapsed/Refractory Hematologic MalignanciesPhase 1
Enitociclib (VIP152)Non-Hodgkin Lymphoma (NHL)Phase 1
BCL-2 Inhibitor ProgramOncologyPreclinical